Home > Healthcare > Cell Culture Media Market > Table of Contents

Cell Culture Media Market – By Product Type (Serum-free Media {CHO, HEK 293, BHK}, Stem-cell Culture Media), Application (Biopharmaceutical Production {Vaccine, Monoclonal Antibodies}, Diagnostics), End-user – Global Forecast (2024 – 2032)

  • Report ID: GMI5538
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1   Market scope & definitions

1.2   Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3   Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4   Forecast model

1.5   Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1   Industry 360° synopsis

Chapter 3   Industry Insights

3.1   Industry ecosystem analysis

3.2   Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising incidence of chronic diseases

3.2.1.2    Advancement in cell culture media technology

3.2.1.3    Increasing demand for serum and animal component-free media

3.2.1.4    Growing demand for regenerative medicine

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost of cell biology products

3.2.2.2    Stringent regulatory challenges

3.3   Growth potential analysis

3.4   Emerging technology landscape

3.5   Porter’s analysis

3.6   PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1   Introduction

4.2   Company matrix analysis

4.3   Company positioning matrix

4.4   Strategic dashboard

Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)

5.1   Key trends

5.2   Serum-free media

5.2.1    CHO media

5.2.2    HEK 293 media

5.2.3    BHK media

5.2.4    VERO cell media

5.2.5    Insect cell media

5.2.6    Immune cell media

5.2.7    Other serum-free media

5.3   Specialty media

5.4   Chemically defined media

5.5   Stem cell culture media

5.6   Other product types

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1   Key trends

6.2   Biopharmaceutical production

6.2.1    Monoclonal antibodies

6.2.2    Vaccine production

6.2.3    Other biopharmaceutical productions

6.3   Diagnostics

6.4   Drug screening and development

6.5   Tissue engineering and regenerative medicine

6.6   Research purpose

6.7   Other applications

Chapter 7   Market Estimates and Forecast, By End-user, 2021 – 2032 ($ Mn)

7.1   Key trends

7.2   Pharmaceutical and biotechnology companies

7.3   Hospital and diagnostic laboratories

7.4   Research and academic institutes

7.5   Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2021– 2032 ($ Mn)

8.1   Key trends

8.2   North America

8.2.1    U.S.

8.2.2    Canada

8.3   Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Rest of Europe

8.4   Asia Pacific

8.4.1    Japan

8.4.2    China

8.4.3    India

8.4.4    Australia

8.4.5    Rest of Asia Pacific

8.5   Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Rest of Latin America

8.6   Middle East and Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    ACROBiosystems

9.2    Corning Incorporation

9.3    Danaher Corporation

9.4    FUJIFILM Irvine Scientific

9.5    Lonza Group

9.6    Merck KGaA

9.7    Miltenyi Biotech

9.8    Nuvonis

9.9    Sartorius AG

9.10   ScienCell Research Laboratories

9.11   Thermo Fisher Scientific Inc.

     

Authors: Mariam Faizullabhoy

Buy Now


Premium Report Details

  • Base Year: 2023
  • Tables & Figures: 228
  • Pages: 142
 Download Free Sample